Business Description
Burzynski Research Institute Inc
NAICS : 325412
SIC : 2834
ISIN : US1231591058
Description
Burzynski Research Institute Inc engages in the research, production, marketing, promotion, and sale of certain medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives and organic acids which are known under the trade name Antineoplastons. Antineoplastons are used in the treatment of human cancer. Its pipeline development programs of the company include clinical trials for the treatment of a wide variety of cancers using only a combination of Antineoplastons A10 and AS2-1.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | -35 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 16.4 | |||||
| 3-Year FCF Growth Rate | 20.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 93.61 | |||||
| 9-Day RSI | 80.17 | |||||
| 14-Day RSI | 70.59 | |||||
| 6-1 Month Momentum % | -35.71 | |||||
| 12-1 Month Momentum % | -10 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.03 | |||||
| Quick Ratio | 0.03 | |||||
| Cash Ratio | 0.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -1.9 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -74250 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -4.62 | |||||
| EV-to-EBITDA | -4.62 | |||||
| EV-to-FCF | -7.44 | |||||
| Earnings Yield (Greenblatt) % | -21.65 | |||||
| FCF Yield % | -8.17 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BZYR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Burzynski Research Institute Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.007 | ||
| Beta | 0.09 | ||
| Volatility % | 130.71 | ||
| 14-Day RSI | 70.59 | ||
| 14-Day ATR ($) | 0.003382 | ||
| 20-Day SMA ($) | 0.03053 | ||
| 12-1 Month Momentum % | -10 | ||
| 52-Week Range ($) | 0.013 - 0.0855 | ||
| Shares Outstanding (Mil) | 131.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Burzynski Research Institute Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Burzynski Research Institute Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Burzynski Research Institute Inc Frequently Asked Questions
What is Burzynski Research Institute Inc(BZYR)'s stock price today?
The current price of BZYR is $0.04. The 52 week high of BZYR is $0.09 and 52 week low is $0.01.
When is next earnings date of Burzynski Research Institute Inc(BZYR)?
The next earnings date of Burzynski Research Institute Inc(BZYR) is .
Does Burzynski Research Institute Inc(BZYR) pay dividends? If so, how much?
Burzynski Research Institute Inc(BZYR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers